Given Abcam News Today

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 373 public companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare Abcam to similar companies based on the strength of its risk, analyst recommendations, institutional ownership, profitability, valuation, earnings and dividends. Profitability This table compares Abcam and […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 449 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Abcam to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, valuation, earnings and risk. Earnings & Valuation This table compares Abcam and […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 449 public companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Abcam to similar businesses based on the strength of its profitability, risk, valuation, analyst recommendations, institutional ownership, dividends and earnings. Profitability This table compares Abcam and […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 397 public companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Abcam to similar businesses based on the strength of its dividends, risk, valuation, profitability, earnings, institutional ownership and analyst recommendations. Dividends Abcam pays an annual dividend […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 380 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Abcam to similar companies based on the strength of its dividends, profitability, earnings, institutional ownership, risk, valuation and analyst recommendations. Insider and Institutional Ownership 43.6% of […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 386 public companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Abcam to related businesses based on the strength of its analyst recommendations, earnings, valuation, risk, dividends, profitability and institutional ownership. Analyst Ratings This is a summary of recent […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 373 public companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare Abcam to related companies based on the strength of its institutional ownership, risk, analyst recommendations, dividends, valuation, profitability and earnings. Profitability This table compares Abcam and its rivals’ […]

Abcam (OTCMKTS:ABCZF – Free Report) is one of 377 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare Abcam to related businesses based on the strength of its earnings, analyst recommendations, valuation, risk, profitability, institutional ownership and dividends. Insider and Institutional Ownership 43.6% of Abcam shares are […]

Abcam (OTCMKTS:ABCZF – Free Report) is one of 376 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Abcam to related companies based on the strength of its valuation, earnings, risk, dividends, analyst recommendations, institutional ownership and profitability. Insider & Institutional Ownership 43.6% of Abcam shares are […]

Abcam (OTCMKTS:ABCZF – Free Report) is one of 360 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Abcam to related companies based on the strength of its profitability, analyst recommendations, dividends, earnings, valuation, institutional ownership and risk. Profitability This table compares Abcam and its competitors’ net […]